相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
M. T. Heneka et al.
Current Alzheimer Research (2012)
Does a Pro-Inflammatory Process Precede Alzheimers Disease and Mild Cognitive Impairment?
M. T. Ferretti et al.
Current Alzheimer Research (2012)
Solanezumab for the treatment of mild-to-moderate Alzheimer's disease
Bruno P. Imbimbo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2012)
Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier
Michelle A. Erickson et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease
Maria Teresa Ferretti et al.
NEUROBIOLOGY OF AGING (2012)
Multi-Target Drugs: The Trend of Drug Research and Development
Jin-Jian Lu et al.
PLOS ONE (2012)
Role of APP for dendritic spine formation and stability
Christian K. E. Jung et al.
EXPERIMENTAL BRAIN RESEARCH (2012)
What the Halted Phase III γ-Secretase Inhibitor Trial May (or May Not) Be Telling Us
Nina F. Schor
ANNALS OF NEUROLOGY (2011)
Multi-Target-Directed Ligands in Alzheimer's Disease Treatment
M. Bajda et al.
CURRENT MEDICINAL CHEMISTRY (2011)
The γ-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease
Annamaria Lanzillotta et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Intraneuronal Amyloid β Oligomers Cause Cell Death Via Endoplasmic Reticulum Stress, Endosomal/Lysosomal Leakage, and Mitochondrial Dysfunction In Vivo
Tomohiro Umeda et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'
Rudy J. Castellani et al.
JOURNAL OF PATHOLOGY (2011)
Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)
F. Mangialasche et al.
LANCET NEUROLOGY (2011)
Resolving controversies on the path to Alzheimer's therapeutics
Dennis J. Selkoe
NATURE MEDICINE (2011)
Mapping the Road Forward in Alzheimer's Disease
David M. Holtzman et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Analysis of microdissected human neurons by a sensitive ELISA reveals a correlation between elevated intracellular concentrations of Aβ42 and Alzheimer's disease neuropathology
Masakazu Hashimoto et al.
ACTA NEUROPATHOLOGICA (2010)
Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease
Gunnar K. Gouras et al.
ACTA NEUROPATHOLOGICA (2010)
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Leslie Crews et al.
HUMAN MOLECULAR GENETICS (2010)
Reimagining Alzheimer's Disease-An Age-Based Hypothesis
Karl Herrup
JOURNAL OF NEUROSCIENCE (2010)
Oral Treatment with a gamma-Secretase Inhibitor Improves Long-Term Potentiation in a Mouse Model of Alzheimer's Disease
Matthew Townsend et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Multiple Events Lead to Dendritic Spine Loss in Triple Transgenic Alzheimer's Disease Mice
Tobias Bittner et al.
PLOS ONE (2010)
Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity
Ralf P. Friedrich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
Claudia Balducci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche et al.
LANCET NEUROLOGY (2010)
Synaptic degeneration in Alzheimer's disease
Thomas Arendt
ACTA NEUROPATHOLOGICA (2009)
CHF5074, a novel γ-secretase modulator, attenuates brain β-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease
B. P. Imbimbo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
γ-Secretase Inhibition Reduces Spine Density In Vivo via an Amyloid Precursor Protein-Dependent Pathway
Tobias Bittner et al.
JOURNAL OF NEUROSCIENCE (2009)
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease
Hyoung-gon Lee et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide
Xiaoyan Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Inhibitors of cathepsin B improve memory and reduce β-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, β-secretase site of the amyloid precursor protein
Vivian Y. H. Hook et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging
Henrieta Scholtzova et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Region-specific changes in the microanatomy of single dendritic spines over time might account for selective memory alterations in ageing hAPPsweTg2576 mice, a mouse model for Alzheimer disease
S. Middei et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
1-(3′,4′-dichloro-2-fluoro[1,1′-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel γ-secretase modulator, reduces brain β-amyloid pathology in a Transgenic mouse model of Alzheimer's disease without causing peripheral toxicity
Bruno P. Imbimbo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Oral vaccination with a viral vector containing Aβ cDNA attenuates age-related Aβ accumulation and memory deficits without causing inflammation in a mouse Alzheimer model
Akihiro Mouri et al.
FASEB JOURNAL (2007)
In vitro and in vivo profiling of CHF5022 and CHF5074 -: Two β-amyloid1-42 lowering agents
Bruno P. Imbimbo et al.
PHARMACOLOGICAL RESEARCH (2007)
Cell division in the CNS: Protective response or lethal event in post-mitotic neurons?
Yan Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Gamma secretase-mediated notch signaling worsens brain damage and functional outcome in ischemic stroke
TV Arumugam et al.
NATURE MEDICINE (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy
TL Spires et al.
JOURNAL OF NEUROSCIENCE (2005)
Dynamics of learning-induced spine redistribution along dendrites of pyramidal neurons in rats
S Knafo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
The γ-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester reduces Aβ levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice
TA Lanz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Consistent immunohistochemical detection of intracellular β-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex
MR D'Andrea et al.
NEUROSCIENCE LETTERS (2002)
Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology
RH Takahashi et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Intracellular A-beta amyloid, a sign for worse things to come?
V Echeverria et al.
MOLECULAR NEUROBIOLOGY (2002)
分享论文
